February 3rd 2021
Test your knowledge of biosimilar approvals in China.
January 20th 2021
Many patient advocates hope that expansion of the Biologics Price Competition and Innovation Act (BPCIA) will bring further competition to the insulin market—and lower prices.
November 16th 2020
The court must decide whether Congress’ setting the shared responsibility payment to $0 means that the entire Affordable Care Act (ACA) statute is now unconstitutional.
October 28th 2020
Opposing interests make it hard to define what elements are essential for a competitive marketplace.
October 12th 2020
There are diverging opinions on whether comparative efficacy trials add much of value to the evidence for biosimilar approval in the United States.
September 25th 2020
How quickly and easily biosimilars should be declared interchangeable with reference products has been an ongoing issue.
